Olema Oncology, Inc. (OLMA) stock

OLMANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 6/30

$7.56+0.04 (+0.53%)

Close on Nov 13, 2026Market cap $661.48MP/E –Yield –

Olema Oncology gross margin

Gross margin is gross profit as a percentage of revenue.

Olema Oncology has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

See a number that looks wrong?